rs759127851

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001480.4(GALR1):​c.115G>A​(p.Val39Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000823 in 1,458,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

GALR1
NM_001480.4 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.53

Publications

0 publications found
Variant links:
Genes affected
GALR1 (HGNC:4132): (galanin receptor 1) The neuropeptide galanin elicits a range of biological effects by interaction with specific G-protein-coupled receptors. Galanin receptors are seven-transmembrane proteins shown to activate a variety of intracellular second-messenger pathways. GALR1 inhibits adenylyl cyclase via a G protein of the Gi/Go family. GALR1 is widely expressed in the brain and spinal cord, as well as in peripheral sites such as the small intestine and heart. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31678343).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALR1NM_001480.4 linkc.115G>A p.Val39Met missense_variant Exon 1 of 3 ENST00000299727.5 NP_001471.2 P47211
GALR1XM_017025691.2 linkc.115G>A p.Val39Met missense_variant Exon 1 of 3 XP_016881180.1
LOC124904329XR_007066422.1 linkn.604+185C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALR1ENST00000299727.5 linkc.115G>A p.Val39Met missense_variant Exon 1 of 3 1 NM_001480.4 ENSP00000299727.3 P47211
ENSG00000309801ENST00000844037.1 linkn.162+185C>T intron_variant Intron 1 of 1
ENSG00000309801ENST00000844038.1 linkn.118+138C>T intron_variant Intron 1 of 1
ENSG00000309801ENST00000844041.1 linkn.159+185C>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD2 exomes
AF:
0.0000205
AC:
5
AN:
243380
AF XY:
0.0000151
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000456
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000823
AC:
12
AN:
1458542
Hom.:
0
Cov.:
37
AF XY:
0.00000827
AC XY:
6
AN XY:
725568
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33396
American (AMR)
AF:
0.00
AC:
0
AN:
44470
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25986
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85966
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51980
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.00000990
AC:
11
AN:
1111126
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 06, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.115G>A (p.V39M) alteration is located in exon 1 (coding exon 1) of the GALR1 gene. This alteration results from a G to A substitution at nucleotide position 115, causing the valine (V) at amino acid position 39 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.0045
Eigen_PC
Benign
0.079
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.32
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
2.5
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.096
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.013
D
Polyphen
0.25
B
Vest4
0.48
MutPred
0.38
Loss of catalytic residue at V39 (P = 0.0028);
MVP
0.72
MPC
0.70
ClinPred
0.44
T
GERP RS
3.9
Varity_R
0.15
gMVP
0.41
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759127851; hg19: chr18-74962619; API